The release of the snapshot containing the respective simulations can be found here:
https://github.com/Open-Systems-Pharmacology/Carbamazepine-Midazolam-DDI/releases/tag/vXX

The carbamazepine-midazolam interaction was evaluated using one clinical DDI study ([Lutz 2018](#4-references)).

| DataID | Enzyme | Perpetrator / victim      | Study design                                                                                                                                                                                                        | Clinical study                  |
| ------ | ------ | ------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ------------------------------- |
| 1460   | CYP3A4 | Carbamazepine / midazolam | Carbamazepine: 100 mg po BID for 2 days, followed by 200 mg po BID for 2 days, followed by 300 mg po BID for 22 days<br />Midazolam: 2 mg po single dose, concomitantly with the 49<sup>th</sup> carbamazepine dose | [Lutz 2018](#4-references)      |
| 943    | CYP3A4 | Carbamazepine / midazolam | Carbamazepine: 100 mg po BID for 2 days, followd by 200 mg po BID for 2 days, followed by 300 mg po for 17 days<br />Midazolam: 1 mg po single dose, 10 hours after the 26<sup>th</sup> carbamazepine dose          | [Kanefendt 2023](#4-references) |
| 1133   | CYP3A4 | Carbamazepine / midazolam | Carbamazepine: 100 mg po BID for 2 days, followd by 200 mg po BID for 2 days, followed by 300 mg po for 18 days<br />Midazolam: 1 mg po single dose, 12 hours after the 28<sup>th</sup> carbamazepine dose          | [Kanefendt 2023](#4-references) |
